Orthofix Medical Inc.
OFIX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000884624
In the last 90 days, Orthofix Medical Inc. insiders filed 1 open-market purchase and 5 sales; 143 institutions reported holding it in 13F filings for Q2 2026, worth $350.1M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $290.2M
- Insider buysLast 90 days, $2.73M in total
- 1
- Insider sellsLast 90 days, $420.0K in total
- 5
- 13F holdersQ2 2026, −2 vs. previous quarter
- 143
- 13F valueReported value at the end of Q2 2026
- $350.1M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $822.3M
- +2.9% year over year
- Net income, FY2025
- -$92.2M
- No comparable prior period
- Free cash flow, FY2025
- -$1.28M
- No comparable prior period
- Revenue, Q3 FY2026
- $207.9M
- +1.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $92.2M (11.2% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.17M
- Shares sold short
- Change
- −218.3K
- −9.1% vs. previous
- Days to cover
- 6.12
- At average daily volume
Superinvestors holding OFIX, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding OFIX at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Orthofix Medical Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 (view filing)4:04 PM ET | Nov 2 | 2 days | Fisher PatrickPresident, Global Limb Recon | SSale | −150 | $9.07 | −$1.36K | −0.3%50.8K after | 10b5-1 |
| Oct 5, 2026 (view filing)4:20 PM ET | Oct 1 | 4 days | Fisher PatrickPresident, Global Limb Recon | SSale | −150 | $9.44 | −$1.42K | −0.3%50.9K after | 10b5-1 |
| Sep 23, 2026 (view filing)3:52 PM ET | Sep 18-21 | 5 days | Michas Alexis P and 2 others10% Owner | PPurchaseCommon Stock, $0.10 par value per share | +310.0K | $8.81 | +$2.73M | +9.0%3.77M after | Amended2 lots |
| Sep 3, 2026 (view filing)4:41 PM ET | Sep 1 | 2 days | Fisher PatrickPresident, Global Limb Recon | SSale | −150 | $9.39 | −$1.41K | −0.3%51.1K after | 10b5-1 |
| Aug 20, 2026 (view filing)5:03 PM ET | Aug 18 | 2 days | Fisher PatrickPresident, Global Limb Recon | SSale | −1.29K | $10.09 | −$13.1K | −2.5%51.2K after | |
| Aug 18, 2026 (view filing)5:05 PM ET | Aug 14-17 | 4 days | Michas Alexis P and 2 others10% Owner | SSaleCommon Stock, $0.10 par value per share | +39.5K | $10.20 | +$402.7K | +87.0%84.9K after | 2 lots |
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | McPherron AvivaPres, Global Ops & Qual | SSale | −3.67K | $9.38 | −$34.4K | −5.2%66.3K after | |
| May 29, 2026 (view filing)4:57 PM ET | May 22 | 7 daysLate | Michas Alexis P and 2 others10% Owner | SSaleCommon Stock, $0.10 par value per share | +242.0K | $10.70 | +$2.59M | +7.5%3.46M after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Henneman John B IIIDirector | PPurchase | +5.00K | $12.26 | +$61.3K | +5.8%90.8K after | |
| May 7, 2026 (view filing)6:15 PM ET | May 5-7 | 2 days | Ajdler Arnaud and 7 others10% Owner | PPurchase | +184.9K | $12.08 | +$2.23M | +93.6%382.4K after | 8 lots |
Top 10 13F holders, Q2 2026
See all 143 holdersThe largest institutional positions in Orthofix Medical Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Engine Capital Management, LP | 4,575,675 | $41.8M | 4.07% | +184,896+4.2% | Added |
| Juniper Investment Company, LLC | 4,442,543 | $40.6M | 10.76% | +465,584+11.7% | Added |
| Rubric Capital Management LP | 3,721,715 | $34.0M | 0.31% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,326,560 | $30.4M | 0.00% | +118,771+3.7% | Added |
| Paradigm Capital Management Inc | 3,300,499 | $30.2M | 0.82% | −4,400−0.1% | Reduced |
| Armistice Capital, LLC | 3,264,000 | $29.8M | 0.83% | +564,000+20.9% | Added |
| Vanguard Capital Management LLC | 1,731,108 | $15.8M | 0.00% | +75,659+4.6% | Added |
| Geode Capital Management, LLC | 1,048,081 | $9.58M | 0.00% | +109,196+11.6% | Added |
| State Street Corp | 953,148 | $8.71M | 0.00% | +45,716+5.0% | Added |
| AQR Capital Management LLC | 887,282 | $8.11M | 0.00% | +698,158+369.2% | Added |
Holders of 5% or more of OFIX
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Orthofix Medical Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Juniper Investment Company, LLC | 13D/A | 11.00%4.44M shares | +1.40 ppfrom 9.60% | Jan 7, 20256 filings | May 27, 2026 | SEC |
| Engine Capital, L.P. | 13D/A | 10.90%4.25M shares | +1.60 ppfrom 9.30% | Nov 3, 20235 filings | May 8, 2025 | SEC |
| Armistice Capital, LLC | 13G/A | 8.01%3.26M shares | +1.28 ppfrom 6.73% | Feb 14, 20248 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.70%2.99M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Armistice Capital, LLC | 13G/A | 7.54%2.98M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |